Form 4 for PCVX Vaxcyte, Inc.
Accepted 2023-12-18 00:00:00 ET · period of report 2023-12-14 · accession 0001209191-23-058943 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-12-18 | 2023-12-14 | PCVX | GUGGENHIME ANDREW | Pres, CFO | M - OptEx | $5.35 | +14.0K | 93.5K | +18% | +$74.9K |
| D | 2023-12-18 | 2023-12-14 | PCVX | GUGGENHIME ANDREW | Pres, CFO | S - Sale+OE | $60.22 | -14.0K | 79.5K | -15% | -$843.1K |
| D | 2023-12-18 | 2023-12-14 | PCVX | GUGGENHIME ANDREW | Pres, CFO | M - OptEx | $0.00 | -14.0K | 400.8K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-14 | M | A | 14,000 | $5.35 | 93,474 | D | — | — | |
| 2 | Common | Common Stock | 2023-12-14 | S | D | 14,000 | $60.22 | 79,474 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2023-12-14 | M | D | 14,000 | $0.00 | 400,827 | D | $5.35 · — to 2030-05-11 | 14,000 Common Stock | (F2) 1/4 of the shares subject to the option vested on May 1, 2021, and 1/48 of the shares vest monthly thereafter. |